Michael Thomas Henderson Apogee Therapeutics, Inc. (APGE) insider trading activity

Shares Held (Direct Ownership) 1.29M

0% 3M change

12.31% 12M change

Total Value Held N/A

MICHAEL THOMAS HENDERSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2025	SELL Open market or private sale	$303,000 $30.3 p/Share	10,000 Reduced 0.77%	1,292,987 Common Stock
Feb 05 2025	SELL Open market or private sale	$608,700 $40.58 p/Share	15,000 Reduced 1.14%	1,302,987 Common Stock
Jan 31 2025	BUY Exercise of conversion of derivative security	$194,310 $22.86 p/Share	8,500 Added 0.64%	1,317,987 Common Stock
Jan 08 2025	SELL Open market or private sale	$735,750 $49.05 p/Share	15,000 Reduced 1.13%	1,309,487 Common Stock
Dec 04 2024	SELL Open market or private sale	$702,600 $46.84 p/Share	15,000 Reduced 1.12%	1,324,487 Common Stock
Nov 06 2024	SELL Open market or private sale	$893,250 $59.55 p/Share	15,000 Reduced 1.11%	1,339,487 Common Stock
Oct 02 2024	SELL Open market or private sale	$2,256,400 $56.41 p/Share	40,000 Reduced 2.87%	1,354,487 Common Stock
Sep 04 2024	SELL Open market or private sale	$1,910,000 $47.75 p/Share	40,000 Reduced 2.79%	1,394,487 Common Stock
Aug 07 2024	SELL Open market or private sale	$1,654,400 $41.36 p/Share	40,000 Reduced 2.71%	1,434,487 Common Stock
Jul 05 2024	SELL Open market or private sale	$558,900 $37.26 p/Share	15,000 Reduced 1.01%	1,474,487 Common Stock

BBIO

BridgeBio Pharma, Inc. Healthcare

Chief Business Officer

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

Director

ARYD

ARYA Sciences Acquisition Corp IV Financial Services

MTH

Chief Executive Officer

Palo Alto, CA

Receive a notification when an Institution or Guru buys or sells APGE shares.

Notify only if

Value

Get notified when an Apogee Therapeutics, Inc. insider buys or sells APGE shares.

Notify only if

Operation

Value

Type

Receive news related to Apogee Therapeutics, Inc.